Prescription and use of ward‐delivered nasal high‐flow oxygen and non‐invasive ventilation for people with acute respiratory failure.
Nasal high‐flow therapy with oxygen entrained (HFNO) and non‐invasive ventilation (NIV) are important therapies for managing acute respiratory failure (ARF) in the ward‐based setting. The European Respiratory Society released guidelines in 2022 recommending the use of HFNO over conventional oxygen t...
| Publicado en: | Internal Medicine Journal Vol. 56; no. 5; pp. 908 - 914 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
May2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |